Triple‐negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer characterized by lack of expression of estrogen receptor (ER) and progesterone receptor (PR) and loss of human epidermal growth factor receptor 2 (HER2) gene amplification. This evidence concerns the gene PGR and breast cancer.